Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» familial chylomicronemia syndrome
familial chylomicronemia syndrome
Ionis' lipid-lowering drug hits phase 3 goal, raising hopes in untapped rare disease market
Fierce Biotech
Tue, 09/26/23 - 11:37 am
Ionis Pharmaceuticals
clinical trials
olezarsen
familial chylomicronemia syndrome
FDA grants fast track designation to Arrowhead Pharmaceuticals’ ARO-APOC3 to reduce triglycerides
Pharmaceutical Business Review
Tue, 03/21/23 - 09:57 am
Arrowhead Pharmaceuticals
ARO-APOC3
triglycerides
familial chylomicronemia syndrome
fast track
FDA
FDA rejects Akcea rare-disease drug that uses gene-blocking technology
Stat
Mon, 08/27/18 - 11:00 pm
FDA
Akcea Therapeutics
Waylivra
familial chylomicronemia syndrome
Could This Drug Help Ionis Stock Recover From a Disappointing 2016?
Motley Fool
Sun, 03/12/17 - 10:49 am
Ionis Pharmaceuticals
volanersorsen
familial chylomicronemia syndrome
Isis Pharmaceuticals Starts Phase III Study on ISIS-APOCIIIRx
Yahoo/Zacks
Sat, 08/30/14 - 10:39 am
Isis Pharmaceuticals
familial chylomicronemia syndrome
ISIS-APOCIIIRx